| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/25/2000 | US6018678 Collecting analyte to be measured in blood or lymph sample |
| 01/25/2000 | US6018080 Atovaquone pharmaceutical compositions |
| 01/25/2000 | US6018033 Hydrophilic, hydrophobic, and thermoreversible saccharide gels and forms, and methods for producing same |
| 01/25/2000 | US6017963 Formulation for intranasal administration |
| 01/25/2000 | US6017948 A pharmaceutically-acceptable anticancer drug paclitaxel in non-aqueous solvent comprising n-methyl pyrrolidone, excluding dimethylacetamide or dimethyl sulfoxide |
| 01/25/2000 | US6017946 Serotonin containing formulation for oral administration and method of use |
| 01/25/2000 | US6017920 Antifungal composition for external use being retentive in stratum corneum |
| 01/25/2000 | US6017900 Topical composition containing hyaluronic acid and nsaids |
| 01/25/2000 | US6017899 Non-reducing saccharide-forming enzyme, its preparation and uses |
| 01/25/2000 | US6017567 Applying a sorbitol syrup to a rotating mass of cores, adding a polyol in a crystalline form comprising at least one member selected from the group consisting of xylitol, erythritol, and isomalt, drying, layering |
| 01/25/2000 | US6017562 Comprising reacting pyrithione or a water-soluble salt of pyrithione and a water-soluble polyvalent metal salt in the presence of a dispersant at 20 degrees c to 60 degrees c to produce non-spherical and/or non-platelet particles |
| 01/25/2000 | US6017560 Process for producing stabilized pharmaceutical composition |
| 01/25/2000 | US6017557 Carriers containing an etherlipid/complementarily shape lipid combination and therapeutic uses thereof |
| 01/25/2000 | US6017554 Composition for treating abnormal conditions of the epithelium of bodily orifices |
| 01/25/2000 | US6017549 Non-irritating cosmetic and pharmaceutical compositions |
| 01/25/2000 | US6017546 Formed by mixing an oil phase with a water phase, the oil phase containing a volatile silicone, a siloxane polyether, and an oil, the water phase containing water, a humectant, and an oxyethylene functional organosilane |
| 01/25/2000 | US6017545 Mixed micellar delivery system and method of preparation |
| 01/25/2000 | US6017531 An extracellular neutral protease and a stabilizer of glyceryl cocoate as a wound healing agent and for debriding necrotic tissue; storage stable enzyme activity at room temperature; burns; cutaneous ulcers; pressure necroses incisional, |
| 01/25/2000 | US6017521 Topically applying a composition comprising water and a water-swellable, water-insoluble, crosslinked, ph buffering, bioadhesive, carboxy-containing addition polymer to acidify; microbiocides; deodorizing |
| 01/25/2000 | US6017520 Penetration enhancement of topically applied therapeutic formulations |
| 01/25/2000 | US6017517 Improving the flexibility of nails by washing the hands with a cleansing composition containing at least 0.5% panthenol for at least about 3 times per day and for at least about ten consecutive days; rinsing |
| 01/25/2000 | US6017515 Using a gel or paste which comprise a group 1a or 2a compound, the anion being, e.g., a chlorite, percarbonate or perborate; cosmetics; antiulcer agents (mouth); injuries; toothpaste; bandages |
| 01/25/2000 | US6017513 Biovector core comprising a natural polymer, e.g., poly- or oligosaccharides, or a hydrolysate; the core is uncoated or coated with a layer of covalently bonded lipid or amphiphilic compound, e.g. a phosphatide; encapsulation; drug delivery |
| 01/25/2000 | CA2205546C Oral compositions containing ondansetron |
| 01/25/2000 | CA2192086C Pellets |
| 01/25/2000 | CA2140478C Medicament having a pediatric presentation for facilitating the absorption thereof by a child |
| 01/25/2000 | CA2107301C Muco adhesive polymers |
| 01/25/2000 | CA2073055C Nicotine containing stimulant unit |
| 01/20/2000 | WO2000003229A1 Method for controlling a coating process |
| 01/20/2000 | WO2000002999A2 Medium and matrix for long-term proliferation of cells |
| 01/20/2000 | WO2000002950A1 Polyester analogue of poly-l-lysine as a soluble, biodegradable gene delivery carrier |
| 01/20/2000 | WO2000002902A1 Novel inhibitors of angiogenesis and tumor growth |
| 01/20/2000 | WO2000002616A1 Methods, systems, and kits for implanting articles |
| 01/20/2000 | WO2000002601A2 Transdermal delivery system |
| 01/20/2000 | WO2000002600A1 Method of obscuring immune recognition |
| 01/20/2000 | WO2000002586A1 Pharmaceutical levothyroxine preparation |
| 01/20/2000 | WO2000002574A1 Powdery preparation for mucosal administration containing polymeric medicine |
| 01/20/2000 | WO2000002570A1 Extracts of zanthoxylum bungeanum, pharmaceutical and cosmetic formulations containing them |
| 01/20/2000 | WO2000002567A1 Water miscible macrolide solutions |
| 01/20/2000 | WO2000002565A1 Injectable sodium acetylsalicylate composition and method |
| 01/20/2000 | WO2000002563A1 Steroid-containing cataplasms and process for producing the same |
| 01/20/2000 | WO2000002560A1 8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDENE)-5H-BENZO[5,6]CYCLOHEPTA[1,2-b]PYRIDINE ORAL COMPOSITIONS |
| 01/20/2000 | WO2000002541A1 Transdermal plaster containing at least one active ingredient which influences blood serum lipid levels |
| 01/20/2000 | WO2000002540A1 Plaster which contains steroids, and a method for the production and use thereof |
| 01/20/2000 | WO2000002539A1 Topical plaster with non-steroidal antirheumatic agents with an acid group |
| 01/20/2000 | WO2000002538A1 Blister containing a transdermal therapeutic system and a single dose form of administration |
| 01/20/2000 | WO2000002537A1 Composition containing glycerol trinitrate, method for producing said composition and use of the same |
| 01/20/2000 | WO2000002536A1 Croscarmellose taste masking |
| 01/20/2000 | WO2000002535A1 Improved stable topical ascorbic acid compositions |
| 01/20/2000 | WO2000002534A1 Kit of drug-containing preparation to be prepared before using and resolvent therefor |
| 01/20/2000 | WO2000002533A2 Dry-copying method for producing flat, individually dosed preparations of active agents |
| 01/20/2000 | WO1999059610A3 Use of lipopeptides or lipoproteins for wound treatment |
| 01/20/2000 | WO1999059541A3 Cyclosporin preparations |
| 01/20/2000 | WO1999059426A3 Crystallization of xylitol, crystalline xylitol product and use thereof |
| 01/20/2000 | WO1999055347A3 Treatment of papilloma virus infection using a mycobacterium |
| 01/20/2000 | WO1999053943A3 Therapeutic angiogenic factors and methods for their use |
| 01/20/2000 | WO1999044604A9 Pharmaceutical compositions containing the phospholipase inhibitor sodium [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-phenylmethyl)-1h-indol-4-yl]oxy]acetate |
| 01/20/2000 | WO1999038472A3 Topical vasodilatory gel composition and methods of use and production |
| 01/20/2000 | WO1998042376A9 Composition comprising immunoglobulin |
| 01/20/2000 | DE19839216C1 Preparation of biocompatible, biodegradable water-insoluble polysaccharide microparticles, used e.g. as fillers for polymers or in diagnostic tests |
| 01/20/2000 | CA2377178A1 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5h-benzo[5,6]cyclohepta[1,2]pyridine oral compositions |
| 01/20/2000 | CA2337680A1 Polyester analogue of poly-l-lysine as a soluble, biodegradable gene delivery carrier |
| 01/20/2000 | CA2337438A1 Novel inhibitors of angiogenesis and tumor growth |
| 01/20/2000 | CA2336888A1 Method for controlling a coating process |
| 01/20/2000 | CA2336789A1 Injectable sodium acetylsalicylate composition and method |
| 01/20/2000 | CA2336748A1 Pharmaceutical preparation |
| 01/20/2000 | CA2336713A1 Dry-copying method for producing flat, individually dosed preparations of active agents |
| 01/20/2000 | CA2336704A1 Composition containing glycerol trinitrate, method for producing said composition and use of the same |
| 01/19/2000 | EP0972825A2 Pellet formulations |
| 01/19/2000 | EP0972526A2 Preparation of diagnostic agents |
| 01/19/2000 | EP0972520A1 Freeze-dried composition of bone morphogenetic protein human mp52 |
| 01/19/2000 | EP0972513A1 Process for preparing emulsified powder |
| 01/19/2000 | EP0972511A1 Association of a retinoid with a histidine derivative |
| 01/19/2000 | EP0971969A1 Biodegradable polymers chain-extended by phosphates, compositions, articles and methods for making and using the same |
| 01/19/2000 | EP0971952A2 Diagnosis method and reagents |
| 01/19/2000 | EP0971908A1 Il-8 receptor antagonists |
| 01/19/2000 | EP0971880A1 Solid compositions suitable for oral administration comprising non hygroscopic salts of l-carnitine and alkanoyl-l-carnitine with 2-aminoethanesulfonic acid |
| 01/19/2000 | EP0971879A1 Solid compositions suitable for oral administration comprising l-carnitine and alkanoyl-l-carnitine magnesium tartrate |
| 01/19/2000 | EP0971746A1 Solvent system for enhanced penetration of pharmaceutical compounds |
| 01/19/2000 | EP0971745A2 Gel delivery vehicles for anticellular proliferative agents |
| 01/19/2000 | EP0971743A1 Stabilized medicaments containing cysteinyl derivatives |
| 01/19/2000 | EP0971729A1 Therapeutic powder formulation for pulmonary administration, containing crystalline insulin |
| 01/19/2000 | EP0971719A1 Therapeutic combination of mineral and vitamin in units of liquid preparation for oral administration |
| 01/19/2000 | EP0971718A1 Combined preparation for oral application of erythromycins |
| 01/19/2000 | EP0971706A2 Vascular remodeling agent |
| 01/19/2000 | EP0971705A1 Hormone replacement therapy drug formulations for topical application to the skin |
| 01/19/2000 | EP0971704A1 Comestible capsules having flavoured coatings |
| 01/19/2000 | EP0971703A1 Use of microparticles having a protein and an antibody adsorbed thereon for preparing a pharmaceutical composition for intranasal administration |
| 01/19/2000 | EP0971702A1 Microgranules containing cisplatin |
| 01/19/2000 | EP0971701A1 Method for removing high boiling solvents from drug formulations by vacuum drying |
| 01/19/2000 | EP0971699A1 Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes |
| 01/19/2000 | EP0971698A1 Aerosolized hydrophobic drug |
| 01/19/2000 | EP0971697A2 Medicament having sclerosing activity |
| 01/19/2000 | EP0971696A1 Thimerosal-free preservatives for vaccines |
| 01/19/2000 | EP0971695A1 Isoflavonoids for treatment and prevention of alzheimer dementia and reduced cognitive functions |
| 01/19/2000 | EP0971694A1 Drug preparations for treating sexual dysfunction |
| 01/19/2000 | EP0971693A2 Method of making microencapsulated dna for vaccination and gene therapy |
| 01/19/2000 | EP0971692A2 Specific magnetosome, method for the production and use thereof |
| 01/19/2000 | EP0971691A2 Combination preparation for orally administered antibiotics |
| 01/19/2000 | EP0971690A1 Antiinfective free intramammary veterinary composition |